$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
COVID-19: Cairo Airport to Receive over 2 M Doses of Pfizer Vaccine
06:59am, Sunday, 20'th Feb 2022 Sada ElBalad English
On Sunday evening, a new shipment of the COVID-19 Pfizer vaccine will arrive at Cairo International Airport, estimated at 2,158,650 doses. Hossam Abdel Ghaffar, spokesman for the Ministry of Health and Population, said that this shipment comes within the framework of the states plan and its keenness to provide vaccines of all kinds to citizens. []
US FDA considers approving second Covid-19 booster shot report
05:09pm, Saturday, 19'th Feb 2022 The Guardian
Wall Street Journal says regulator could authorize fourth shots of Pfizer and Moderna vaccines by the fall US health regulators are looking at authorizing a potential fourth dose of a Covid-19 vaccine in the fall, the Wall Street Journal reported on Saturday, citing sources familiar with the matter. The Food and Drug Administration (FDA) has been reviewing data to authorize a second booster dose of vaccines from Pfizer and BioNTech and Moderna, the report added . Continue reading
US health regulators consider approving 2nd COVID-19 booster shot: Report
04:15pm, Saturday, 19'th Feb 2022 Livemint
The Food and Drug Administration has been reviewing data to authorise a second booster dose of the messenger RNA vaccines from Pfizer Inc and partner BioNTech SE and vaccines from Moderna Inc
WSJ News Exclusive | FDA Eyes Second Covid-19 Booster Shot
03:00pm, Saturday, 19'th Feb 2022 The Wall Street Journal
The agency has begun reviewing data that could lead to clearing a second booster dose of the Pfizer and Moderna vaccines in the fall, if they are found to work safely.
Covid19 care committee report sent to Health Ministry, PM
06:40pm, Friday, 18'th Feb 2022 News Day
HEALTH Minister Terrence Deyalsingh said the report prepared by the covid19 care committee headed by Prof Terence Seemungal, dean of the Faculty of Medical Sciences, University of the West Indies, St Augustine, has been completed and handed over to the ministry. Speaking at the Health Ministry’s covid19 media briefing on Wednesday, Deyalsingh said the report was presented to him on Tuesday. “The committee asked for an extension up to February 14. They complied with the extension and presented the report to me on Tuesday at 1 pm. On receiving the report, we started a deep dive into it and also simultaneously I sent a copy to the Prime Minister because this was his initiative. "As far as making it public, the PM is on record, and he announced at a press conference at the Diplomatic Centre, that he will make it public. The timing as to when it will be made public is at the prerogative of the PM.” On January 15, Dr Rowley announced that Seemungal would lead an eminently qualified five-man committee to review the operations of health care facilities, in light of criticism in some quarters that substandard care was contributing to the large number of covid19 related deaths in the country.
Revealed: Why no foreign pharma firm could manufacture COVID-19 vaccine in India
06:37pm, Friday, 18'th Feb 2022 Zee Business
Moderna and Pfizer''s vaccine were seeing India as a big market.
Talks did not materialise, says Niti Aayog''s VK Paul on Pfizer and Moderna
05:52pm, Friday, 18'th Feb 2022 India Today
Talks did not materialise, says Niti Aayog''s VK Paul on Pfizer and Moderna
Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline
05:50pm, Friday, 18'th Feb 2022 Benzinga
Moderna Inc (NASDAQ: MRNA ) said it is developing three new vaccines based on the same technology used for its COVID-19 shot, including one for viral infection shingles. The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer Inc (NYSE: PFE ) / BioNTech SE (NASDAQ: BNTX ) has prompted efforts to use the novel … Full story available on Benzinga.com
Pfizer COVID vaccine for kids delayed because of efficacy against Omicron - WSJ
04:22pm, Friday, 18'th Feb 2022 Seeking Alpha
The FDA delayed a review of Pfizer (PFE) request to expand authorization of its COVID-19 vaccine to children under the age of 5 because of concerns the two-dose series wasnt effective.
Low Omicron efficacy behind delay of Pfizer COVID-19 vaccine for kids under 5, says report
03:45pm, Friday, 18'th Feb 2022 Channel NewsAsia
US health regulators delayed the review of Pfizer''s COVID-19 vaccine for children under 5 years of age because its two-dose regimen did not work well against the Omicron variant, the Wall Street Journal reported on Friday (Feb 18). Last week, the US Food and Drug Administration (FDA) said it need
3 Charts That Show Just How Ridiculously Massive Pfizer''s COVID-19 Revenue Will Be in 2022
03:30pm, Friday, 18'th Feb 2022 The Motley Fool
It''s even more than the revenue the company has posted in previous years.
Lower Omicron Efficacy Led to FDA Delay on Pfizer Shot in Young Kids
02:18pm, Friday, 18'th Feb 2022 The Wall Street Journal
Regulators opted to take more time to review the shot in that age group because the two-dose series so far wasn’t working well against the new variant during testing, people familiar with the move said.
WSJ News Exclusive | Lower Omicron Efficacy Delayed FDA Review on Pfizer Shot in Kids Under 5
02:00pm, Friday, 18'th Feb 2022 The Wall Street Journal
Regulators opted to take more time to review the shot in that age group because the two-dose series so far wasn’t working well against the new variant during testing, people familiar with the move said.
Uruguay will move forward with fourth dose of Pfizer’s vaccine
01:13pm, Friday, 18'th Feb 2022 The Rio Times
RIO DE JANEIRO, BRAZIL - The Vaccine Advisory Commission made a new recommendation to the Ministry of Public Health to reinforce the doses of covid-19 vaccine in parts of the population. Fourth doses of The post Uruguay will move forward with fourth dose of Pfizer’s vaccine appeared first on The Rio Times .
Canada Approves “Novavax” COVID-19 Vaccine for Adults
09:59am, Friday, 18'th Feb 2022 Sada ElBalad English
Canada approved, on Thursday, the Novavax COVID-19 vaccine for people aged 18 and over. The announcement makes “Novavax” the fifth COVID-19 vaccine authorized in the country after AstraZeneca, Moderna, Pfizer and Johnson & Johnson. In a news release, Health Canada said the vaccine is 90% effective at preventing symptomatic COVID-19 and 100% effective at preventing […]
Sign In
Buy PFE